A pilot study of the phase angle between cortisol and melatonin in major depression – A potential biomarker?
Authors:
- Theresa M. BuckleyTBTheresa M. Buckley
- Alan F. SchatzbergASAlan F. Schatzberg
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 44 (2) , 69-74
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Medical disorders in people with recurrent depressionThe British Journal of Psychiatry, 2008
- The circadian basis of winter depressionProceedings of the National Academy of Sciences, 2006
- Clinical efficacy of agomelatine in depression: the evidenceInternational Clinical Psychopharmacology, 2006
- The basic physiology and pathophysiology of melatoninSleep Medicine Reviews, 2005
- Evidence for a biological dawn and dusk in the human circadian timing systemThe Journal of Physiology, 2001
- Evidence for Mineralocorticoid Receptor Facilitation of Glucocorticoid Receptor-Dependent Regulation of Hypothalamic-Pituitary-Adrenal Axis ActivityEndocrinology, 1998
- Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone releaseBrain Research, 1992
- Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patientsActa Psychiatrica Scandinavica, 1987
- Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression testPsychoneuroendocrinology, 1985
- MELATONIN AND CORTISOL LEVELS IN PSYCHIATRIC ILLNESSThe Lancet, 1982